Compare SGBX & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGBX | TRIB |
|---|---|---|
| Founded | 2007 | 1992 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.0M | 18.3M |
| IPO Year | 2017 | N/A |
| Metric | SGBX | TRIB |
|---|---|---|
| Price | $2.41 | $0.94 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 13.7M | 111.9K |
| Earning Date | 11-14-2025 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $3,382,896.00 | ★ $61,555,000.00 |
| Revenue This Year | $1,628.82 | $13.51 |
| Revenue Next Year | N/A | $13.14 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 8.31 |
| 52 Week Low | $1.81 | $0.48 |
| 52 Week High | $122.88 | $3.44 |
| Indicator | SGBX | TRIB |
|---|---|---|
| Relative Strength Index (RSI) | 41.57 | 44.46 |
| Support Level | $3.30 | $0.88 |
| Resistance Level | $4.05 | $1.05 |
| Average True Range (ATR) | 0.51 | 0.11 |
| MACD | -0.14 | -0.01 |
| Stochastic Oscillator | 2.36 | 14.29 |
Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.